Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium - Wikidata - wikimedia - TriplyDB

Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium

Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium

http://www.wikidata.org/entity/Q34492675

about

Transcatheter valve implantation versus aortic valve replacement for aortic stenosis in high-risk patients Transcatheter versus optimal medical treatment and surgical aortic valve replacement for aortic valve stenosis Transcatheter versus optimal medical treatment and surgical aortic valve replacement for aortic valve stenosis Transcatheter valve implantation versus aortic valve replacement for aortic stenosis in high-risk patients Acute kidney injury after transcatheter aortic valve implantation Advanced 3-D analysis, client-server systems, and cloud computing-Integration of cardiovascular imaging data into clinical workflows of transcatheter aortic valve replacement Impact of renal dysfunction on mid-term outcome after transcatheter aortic valve implantation: a systematic review and meta-analysis Echocardiographic imaging of procedural complications during balloon-expandable transcatheter aortic valve replacement.Limitations and difficulties of echocardiographic short-axis assessment of paravalvular leakage after corevalve transcatheter aortic valve implantation.Emergency cardiac surgery during transfemoral and transapical transcatheter aortic valve implantation: incidence, reasons, management, and outcome of 411 patients from a single center.Practical update on imaging and transcatheter aortic valve implantation.The impact of transcatheter aortic valve implantation on left ventricular performance and wall thickness - single-centre experience.Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies.Initial experience of two national centers in transcatheter aortic prosthesis implantation.Should Transcatheter Aortic Valve Replacement Be Performed in Nonagenarians?: Insights From the STS/ACC TVT Registry.TAVI: New trials and registries offer further welcome evidence - U.S. CoreValve, CHOICE, and GARY Percutaneous management of vascular access in transfemoral transcatheter aortic valve implantation.Third universal definition of myocardial infarction.Morbidity and mortality of nonagenarians undergoing CoreValve implantation.Predictive factors for pacemaker requirement after transcatheter aortic valve implantation.Prognostic utility of biomarkers in predicting of one-year outcomes in patients with aortic stenosis treated with transcatheter or surgical aortic valve implantation.The importance of contrast volume/glomerular filtration rate ratio in contrast-induced nephropathy patients after transcatheter aortic valve implantation Sutureless Aortic Valve Replacement International Registry (SU-AVR-IR): design and rationale from the International Valvular Surgery Study Group (IVSSG)Prophylactic intraoperative tranexamic acid administration and postoperative blood loss after transapical aortic valve implantation.Patients with aortic stenosis referred for TAVI: treatment decision, in-hospital outcome and determinants of survival Valvular leak after transcatheter aortic valve implantation: a clinician update on epidemiology, pathophysiology and clinical implications Feasibility of a new method using two-dimensional transesophageal echocardiography for aortic annular sizing in patients undergoing transcatheter aortic valve implantation; a case-control study.Two-dimensional transesophageal echocardiography for aortic annular sizing in patients undergoing transcatheter aortic valve implantation ESC Working Group on Valvular Heart Disease Position Paper: assessing the risk of interventions in patients with valvular heart disease.Comparison of Manual and Automated Preprocedural Segmentation Tools to Predict the Annulus Plane Angulation and C-Arm Positioning for Transcatheter Aortic Valve Replacement The risk-to-benefit ratio of transcatheter aortic valve implantation in specific patient cohorts: a single-centre experience Early- and mid-term outcomes after transcatheter aortic valve implantation. Data from a single-center registry.The Nordic aortic valve intervention (NOTION) trial comparing transcatheter versus surgical valve implantation: study protocol for a randomised controlled trial Impact of age on transcatheter aortic valve implantation outcomes: a comparison of patients aged ≤ 80 years versus patients > 80 years.Prevalence of blood type A and risk of vascular complications following transcatheter aortic valve implantation.Self-expandable transcatheter aortic valve implantation for aortic stenosis after mitral valve surgery.A review of most relevant complications of transcatheter aortic valve implantation Transcatheter resection of the native aortic valve prior to endovalve implantation - A rational approach to reduce TAVI-induced complications.Transapical aortic valve implantation - The Leipzig experience.3-year outcomes of self-expanding Corevalve prosthesis - The Italian Registry

P2860

Q24186902-F81B7D84-8FEA-43BA-A219-79B241EDCD1D Q24188266-1B7FEAAF-6C5A-42F0-944C-5F56D74C2639 Q24198166-9B8E22B2-057F-4CF9-9605-E6C14055DB61 Q24202046-8817BAAD-B4BA-42A1-ACDD-4151C7735D5C Q26778728-7480F89D-C2F8-4B63-909C-42A3B5CE7312 Q26825472-5683EC1A-17A7-4F93-AD08-7D6B92838FF3 Q27008295-086A982A-5665-42BE-8E58-B5EDB7A52104 Q27310075-55B32DE4-0443-4EAB-8CE4-35D647709DEF Q28075918-DFAF2AB9-4035-4B8E-B86E-909A0051FFD8 Q30317795-99A25A1E-9860-4B2C-9544-1DECA1B45CF2 Q30413611-58F3380A-F117-42C7-90FD-8BF55D769B07 Q30414871-2DB0FC3A-F276-412D-BF39-27A5325B4447 Q31122441-A5F26F6E-2827-46C7-9CD6-7CC6D999F5E5 Q33641522-35E0F78F-4E41-467B-B034-FD23740F019D Q33725292-C6407422-1857-47AC-9054-4ECFF98BD22D Q33923803-BAD396BF-5F20-4B3F-A68A-2E7DE71116D6 Q34179085-81C23E4E-EDE2-44D4-977C-93269BE07AA8 Q34295914-ED148467-CF42-4A71-8814-E7BEEA92D4AB Q34420256-6E5D6E3C-EFAE-46E0-B7FB-BC83A581B171 Q34433533-65075648-EA01-43B7-9F9D-19A60B33E1F8 Q34524804-890F7C87-A3A2-43F9-9493-62E4EB751A10 Q35081498-FD6324D7-E45C-45A3-A50B-ADFC10EBF6E7 Q35257052-A185F808-5581-4BE3-A4B8-823F6E255E73 Q35368507-90B344D1-C12F-4E59-A4C4-60C38DEA3E64 Q35638580-E13420C9-13C3-4BF0-B4F7-59C7092C6BA9 Q35660174-C6A23B68-BE0B-4637-9B47-9FAAAD16D9AF Q35717728-D94C1719-CA99-4AFF-B72F-FE90AC778E21 Q35881258-FA0C170B-0457-481C-8FFC-0572C0F3A004 Q35937749-8DAF0C74-B1A2-46C1-8A44-AB02E1192AF7 Q35988315-47737599-6DF2-44B3-9D70-723793A22AC7 Q36041201-A8F3471B-1C28-4C34-91DC-8D783E13A8A2 Q36046152-CD5464BD-930C-40B8-8903-2AC209085EF0 Q36552792-B3CFFC07-DD28-4A8B-8C31-F7B161FE8E89 Q36578428-733C15FE-A1A8-4C9F-8CA0-08097205E3C1 Q36823438-B0EF248D-DA50-4BC7-A7E8-0514691C2297 Q36939813-AD8CCD67-D297-4CA9-8CD1-49ABDD6D1539 Q36988450-4D6A7CAE-03BB-4A1E-B625-1E574239ECB9 Q37090708-86D45BB7-F844-407C-A252-3E9610D6FE49 Q37090731-8E605A6B-86AE-4DE1-8B21-1AD3877F8742 Q37090755-BBE8A0EC-76BC-4329-96B3-63947188989F

P2860

Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium

http://www.wikidata.org/entity/Q34492675

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Standardized endpoint definiti ...... e Academic Research Consortium

@ast

Standardized endpoint definiti ...... e Academic Research Consortium

@en

Standardized endpoint definiti ...... e Academic Research Consortium

@nl

type

label

Standardized endpoint definiti ...... e Academic Research Consortium

@ast

Standardized endpoint definiti ...... e Academic Research Consortium

@en

Standardized endpoint definiti ...... e Academic Research Consortium

@nl

prefLabel

Standardized endpoint definiti ...... e Academic Research Consortium

@ast

Standardized endpoint definiti ...... e Academic Research Consortium

@en

Standardized endpoint definiti ...... e Academic Research Consortium

@nl

P1433

Q34492675-0E3691F5-7E50-4F79-A190-46D1FBBB96D6

P1476

Q34492675-5760DD36-D3EE-40D9-B22D-D9B5ADD0CF57

P2093

Q34492675-202FC001-28BC-48CC-8099-DE459445DCB2

Q34492675-23F4D7BF-CA13-47C4-B0D0-732349EFA540

Q34492675-2DF5DCA3-3950-413D-9486-81462A063C1B

Q34492675-4859EE16-6914-420C-9680-61129A827463

Q34492675-4F0FF97F-9B36-4EC0-8614-33AB65F744D7

Q34492675-870185F6-EA79-4140-AE9A-66F0129981E7

Q34492675-881631BE-6978-4A84-AB4E-D7A057C368E6

Q34492675-A5274C0B-BF92-4E1C-A1F4-27D4F33092ED

Q34492675-C7A2BAB7-E82B-4FFB-811E-CC81F8BC875D

Q34492675-C8C7F969-12A8-47E0-8C9E-96752C143C14

P275

Q34492675-4BCD277A-85C6-4D2B-937C-0E1A3B56AF27

P2860

Q34492675-02E90E7C-B996-42F7-88D0-63FDF5DEA4B7

Q34492675-04A26412-1F79-481B-9150-E31AD994445A

Q34492675-0AC6EF5A-DAD8-402D-858C-3BE1589E5549

Q34492675-0D384A15-FBE4-4C51-AC88-433373C5F84D

Q34492675-0EE3AD97-B6D3-43C8-B1E8-B47725AE5DF4

Q34492675-14D87D33-1FEE-4721-8571-EAE5CB578BF1

Q34492675-17441B6C-4619-4799-A9C3-B42A839B2B7A

Q34492675-184C4824-932B-4D99-AFC5-98885BAD1F34

Q34492675-19C38961-1A42-453B-9B8D-111A7BDE4592

Q34492675-1B82BAB8-5638-4E88-9782-C8D472BA0613

P304

Q34492675-811A6BB0-6DCB-49DB-8B2A-E9DB24E10D97

P31

Q34492675-DDC7BBC0-DC9F-46CA-9783-BDA0404C79D1

P356

Q34492675-42E3C3F4-483C-419E-9FC3-3841DF0CC2E6

P433

Q34492675-B9DA5576-671D-4353-8B62-8E7044B91D37

P478

Q34492675-271B3504-DFA1-475B-B925-0B1DFC57BDB8

P50

Q34492675-047E160A-0E4F-4365-8841-1377F102C17E

Q34492675-903836A9-8F2C-4ECA-B3D9-174F46AFDA06

Q34492675-B6DD5DFD-B7DE-4471-B6BD-9A4BFDA46521

Q34492675-D46AE09D-71B7-4494-BD24-EFC98BF1697E

P577

Q34492675-14B38037-7877-48CF-AA5D-4F0173865696

Q34492675-313C877F-FDD9-4882-B673-F8D42B203F65

P5875

Q34492675-C00EF79E-1A1D-417F-BA54-9FA6D5A50EAD

P698

Q34492675-9C03A306-B624-4FE2-A3F3-38EFDF25B636

P921

Q34492675-02434436-0B44-49A1-AE7D-815EF0CD5A69

Q34492675-11CC674E-4AD9-4B07-B564-4E058DA0A8BB

P932

Q34492675-68A151EC-619B-4F9A-858C-85AA034611E1

P356

P1433

European Heart Journal

P1476

Standardized endpoint definiti ...... e Academic Research Consortium

@en

P2093

Alec Vahanian

http://www.w3.org/2001/XMLSchema#string

Arie Pieter Kappetein

http://www.w3.org/2001/XMLSchema#string

Craig Miller

http://www.w3.org/2001/XMLSchema#string

Donald E Cutlip

http://www.w3.org/2001/XMLSchema#string

Eugene H Blackstone

http://www.w3.org/2001/XMLSchema#string

Eugenia Nikolsky

http://www.w3.org/2001/XMLSchema#string

Gerrit-Anne van Es

http://www.w3.org/2001/XMLSchema#string

Johanna J M Takkenberg

http://www.w3.org/2001/XMLSchema#string

John G Webb

http://www.w3.org/2001/XMLSchema#string

John Petersen

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group

Definition and Evaluation of Transient Ischemic Attack

Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide

Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial

Frailty in older adults: evidence for a phenotype

Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial

Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase

Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description

2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: de

P304

205-217

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHQ406

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Patrick W Serruys

Stephan Windecker

Jeffrey J Popma

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2011-01-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49738791

http://www.w3.org/2001/XMLSchema#string

P698

21216739

http://www.w3.org/2001/XMLSchema#string

P921

aortic valve stenosis

P932

3021388

http://www.w3.org/2001/XMLSchema#string